News

Dear Subscribers, QUAMED (www.quamed.org) is a not-for-profit organisation specialising in various aspects of pharmaceutical quality assurance. We conduct pharmaceutical assessments and audits, we develop and facilitate training courses around pharmaceutical quality, auditing and inspection and we organise and provide technical assistance in the field of pharmaceutical quality assurance. We have started two projects that have ...

Pharmaceutical public health is an emerging field in global health -and global health needs a generation of policy-makers who understand the relevance of coherent and integrated pharmaceutical systems. Pharmaceutical systems are essential to provide equitable, affordable access to appropriately used essential medical products. Unfortunately, they face major challenges in many countries, like the lack of ...

This WHO Medical Product Alert refers to one batch of falsified Combiart (combination of artemether and lumefantrine) that was identified in Chad, Côte d’Ivoire, and Mali and reported to WHO in November 2021. The falsified product was reported at the patient level outside authorized and regulated supply chains of the above-mentioned countries.Genuine Combiart is indicated ...

Dear members and partners, We would like to thank you for the wonderful opportunities that you have offered us in 2021. Despite the ongoing pandemic, you have been instrumental in helping us recover from a year with almost no activities (2020) and have made 2021, the most successful year yet for QUAMED We would like ...

Our auditor, Mr. George Mugi, has finalised 4 GSDP audits in Mozambique and has returned home safely. Our pipeline is filling up: we are preparing local market assessments (LMA) in Chad, Sudan, Yemen, Myanmar and Nigeria. In January 2022, we have planned up to 6 MQAS audits in Turkey and Mozambique and 8 GSDP technical ...

We are happy to announce that the board of QUAMED has accepted the membership application of Dr Prosper Hiag. Dr Hiag is a leader in the pharmaceutical sector, a social entrepreneur and an advocate for access to quality medicines in Africa and the use of WHO Good Manufacturing Practices for drugs conception and promoter of local ...

We are happy to announce that Anthony Bourasseau has joined the QUAMED operational team as the Quality and Compliance Coordinator (part-time). He will have the overall responsibility of QUAMED’s quality assurance policy. Anthony has a doctorate in Pharmaceutical Sciences and a master degree in Total Quality Management and Biotechnologies, both from the University of Angers ...

QUAMED activities: After having concluded two successful MQAS audits in Malawi earlier this month, our auditor Mr George Mugi, has started the first of four GSDP audits of laboratory supplies wholesalers in Mozambique on Monday the 22nd of November. He will be in Maputo for almost two weeks.

QUAMED has benefitted from pro-bono support from different law firms in Paris and Brussels since early this year. For our transfer from France to Belgium this is very useful but also to ensure that our contracts and agreements are according to France and Belgium law. A Pro-Bono event is taking place on the afternoon of ...